CompoSecure (CMPO) Financials

$20.62 0.00 (0.00%)

Closing price 03:59 PM Eastern

Extended Trading

$20.59 -0.03 (-0.15%)

As of 07:56 PM Eastern

Annual Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	81	78	3.15	19	19	-54
Consolidated Net Income / (Loss)	81	78	83	132	113	-83
Net Income / (Loss) Continuing Operations	81	78	83	132	113	-83
Total Pre-Tax Income	81	78	83	136	117	-81
Total Operating Income	87	84	81	115	119	108
Total Gross Profit	128	133	145	220	209	219
Total Revenue	243	261	268	378	391	421
Operating Revenue	243	261	268	378	391	421
Total Cost of Revenue	115	128	123	159	182	201
Operating Cost of Revenue	115	128	123	159	182	201
Total Operating Expenses	41	49	63	105	90	112
Selling, General & Admin Expense	41	49	63	105	90	112
Total Other Income / (Expense), net	-5.45	-6.14	1.13	21	-2.01	-189
Interest Expense	-	-	-	21	28	20
Interest & Investment Income	-4.75	-5.27	-10	1.25	4.98	4.65
Other Income / (Expense), net	-0.70	-0.88	11	41	21	-173
Income Tax Expense	0.00	0.00	-0.86	4.36	4.56	2.19
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	80	113	93	-29
Basic Earnings per Share	$0.00	$0.00	$0.21	$1.21	$1.03	($1.22)
Weighted Average Basic Shares Outstanding	0.00	0.00	14.93M	15.37M	18.66M	44.01M
Diluted Earnings per Share	$0.00	$0.00	$0.12	$1.13	$0.96	($1.22)
Weighted Average Diluted Shares Outstanding	0.00	0.00	94.57M	32.56M	35.31M	44.01M
Weighted Average Basic & Diluted Shares Outstanding	-	-	76.07M	77.88M	80.53M	102.31M

This table shows CompoSecure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	2.82	3.97	2.33	5.74	7.48	3.70	4.03	11	-42	-27	21
Consolidated Net Income / (Loss)	22	22	11	33	38	31	17	34	-85	-48	21
Net Income / (Loss) Continuing Operations	22	22	11	33	38	31	17	34	-85	-48	21
Total Pre-Tax Income	22	23	9.47	34	39	35	16	34	-85	-46	34
Total Operating Income	26	25	29	30	29	31	31	32	29	16	6.04
Total Gross Profit	62	50	53	54	49	53	55	56	55	53	29
Total Revenue	103	94	95	99	97	100	104	109	107	101	60
Operating Revenue	103	94	95	99	97	100	104	109	107	101	60
Total Cost of Revenue	42	44	42	45	48	47	49	52	52	48	31
Operating Cost of Revenue	42	44	42	45	48	47	49	52	52	48	31
Total Operating Expenses	36	25	24	24	20	22	24	24	26	37	23
Selling, General & Admin Expense	36	25	24	24	20	22	24	24	26	37	23
Total Other Income / (Expense), net	-3.36	-1.69	-20	3.33	10	4.40	-15	2.06	-114	-62	28
Interest Expense	-	-	-	-	0.00	-	6.54	-	0.15	-	1.69
Interest & Investment Income	-5.30	16	-5.93	-5.44	-5.70	22	1.12	-5.32	-5.14	21	0.22
Other Income / (Expense), net	1.94	3.90	-14	8.77	16	9.88	-9.48	7.38	-109	-62	29
Income Tax Expense	0.39	0.62	-1.26	0.97	0.95	3.90	-0.84	0.26	0.63	2.14	27
Other Gains / (Losses), net	-	-	-	-	-	-	0.00	-	-	-	15
Net Income / (Loss) Attributable to Noncontrolling Interest	19	18	8.41	27	31	27	13	22	-43	-22	0.00
Basic Earnings per Share	$0.18	$0.24	$0.13	$0.31	$0.39	$0.20	$0.20	$0.44	($1.10)	($0.76)	$0.21
Weighted Average Basic Shares Outstanding	15.43M	15.37M	17.63M	18.54M	19.07M	18.66M	20.57M	25.44M	38.21M	44.01M	102.04M
Diluted Earnings per Share	$0.18	$0.20	$0.11	$0.29	$0.34	$0.22	$0.17	$0.32	($1.10)	($0.61)	$0.07
Weighted Average Diluted Shares Outstanding	19.66M	32.56M	94.74M	35.53M	35.76M	35.31M	96.24M	96.64M	38.21M	44.01M	113.27M
Weighted Average Basic & Diluted Shares Outstanding	76.35M	77.88M	78.39M	79.00M	79.32M	80.53M	80.59M	81.91M	88.13M	102.31M	102.32M

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	14	-13	8.52	-8.30	28	36
Net Cash From Operating Activities	81	87	78	93	104	130
Net Cash From Continuing Operating Activities	81	87	78	93	104	130
Net Income / (Loss) Continuing Operations	81	78	83	132	113	-83
Consolidated Net Income / (Loss)	81	78	83	132	113	-83
Depreciation Expense	8.61	9.92	10	8.58	8.39	9.17
Amortization Expense	0.67	0.84	1.65	2.35	1.55	1.16
Non-Cash Adjustments To Reconcile Net Income	1.21	3.01	3.23	-29	-5.77	193
Changes in Operating Assets and Liabilities, net	-11	-4.52	-21	-21	-12	9.48
Net Cash From Investing Activities	-9.64	-7.50	-4.75	-9.05	-11	-9.95
Net Cash From Continuing Investing Activities	-9.64	-7.50	-4.75	-9.05	-11	-9.95
Purchase of Property, Plant & Equipment	-9.64	-7.50	-4.75	-9.05	-11	-8.45
Other Investing Activities, net	-	-	-	0.00	0.00	-1.50
Net Cash From Financing Activities	-58	-93	-65	-92	-66	-83
Net Cash From Continuing Financing Activities	-58	-93	-65	-92	-66	-83
Repayment of Debt	-30	-14	-247	-32	-23	-15
Payment of Dividends	-104	-217	-241	-36	-38	-59
Issuance of Common Equity	0.00	0.00	61	0.08	1.20	5.00
Other Financing Activities, net	0.00	0.00	-15	-24	-5.56	-14
Cash Interest Paid	4.89	5.32	10	21	27	21
Cash Income Taxes Paid	-	-	0.00	0.86	2.76	4.82

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	2.04	-1.79	8.92	0.05	1.20	17	14	-20	17	25	-68
Net Cash From Operating Activities	31	11	25	28	25	26	34	32	28	35	3.01
Net Cash From Continuing Operating Activities	31	11	25	28	25	26	34	32	28	35	3.01
Net Income / (Loss) Continuing Operations	22	22	11	33	38	31	17	34	-85	-48	21
Consolidated Net Income / (Loss)	22	22	11	33	38	31	17	34	-85	-48	21
Depreciation Expense	2.01	2.00	2.04	2.13	2.08	2.14	2.22	2.38	2.33	2.24	1.62
Amortization Expense	0.55	0.55	0.56	0.14	0.56	0.28	0.35	0.32	0.29	0.20	0.07
Non-Cash Adjustments To Reconcile Net Income	5.13	-21	15	-2.81	-1.03	-17	14	-1.01	80	102	-40
Changes in Operating Assets and Liabilities, net	0.99	6.51	-3.93	-4.08	-15	10	-0.02	-3.04	31	-20	20
Net Cash From Investing Activities	-3.72	-1.83	-3.67	-2.03	-0.97	-4.28	-1.61	-1.91	-1.98	-4.43	-61
Net Cash From Continuing Investing Activities	-3.72	-1.83	-3.67	-2.03	-0.97	-4.28	-1.61	-1.91	-1.98	-4.43	-61
Purchase of Property, Plant & Equipment	-3.72	-1.83	-3.67	-2.03	-0.97	-4.28	-1.61	-1.91	-1.98	-2.93	-0.39
Other Investing Activities, net	-	-	-	-	-	-	0.00	-	-	-	-60
Net Cash From Financing Activities	-25	-11	-12	-26	-23	-4.76	-18	-50	-8.87	-6.20	-10
Net Cash From Continuing Financing Activities	-25	-11	-12	-26	-23	-4.76	-18	-50	-8.87	-6.20	-10
Repayment of Debt	-5.00	-10	-0.33	-4.69	-13	-4.69	-4.69	-4.69	-2.85	-2.70	0.00
Payment of Dividends	-9.82	-0.75	-9.71	-19	-9.35	-	-10	-25	-24	-	0.00
Issuance of Common Equity	0.00	0.08	0.15	0.24	0.64	0.17	0.11	0.11	2.67	2.10	0.12
Other Financing Activities, net	-	-0.11	-2.41	-2.27	-0.64	-0.24	-3.48	-21	16	-5.60	-10
Cash Interest Paid	5.30	6.44	4.57	9.06	4.67	8.95	4.18	8.72	4.10	3.62	2.16

This table presents CompoSecure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	81	131	163	201	474
Total Current Assets	53	78	97	139	174
Cash & Equivalents	13	22	14	41	77
Accounts Receivable	8.79	28	37	40	47
Inventories, net	30	26	42	53	45
Prepaid Expenses	1.08	2.60	3.82	5.13	4.16
Plant, Property, & Equipment, net	28	22	23	25	23
Total Noncurrent Assets	0.01	31	43	36	277
Long-Term Investments	-	-	-	-	0.00
Noncurrent Deferred & Refundable Income Taxes	0.00	26	26	24	265
Other Noncurrent Operating Assets	0.01	5.26	18	13	12
Total Liabilities & Shareholders' Equity	81	131	163	201	474
Total Liabilities	274	539	455	407	617
Total Current Liabilities	42	61	47	41	76
Short-Term Debt	24	13	14	10	11
Accounts Payable	2.42	7.06	7.13	5.19	12
Accrued Expenses	12	10	10	12	15
Current Deferred & Payable Income Tax Liabilities	-	-	2.37	1.43	5.17
Other Current Liabilities	3.64	31	13	12	34
Total Noncurrent Liabilities	232	478	408	366	541
Long-Term Debt	232	375	344	326	184
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	24	24	249
Other Noncurrent Operating Liabilities	0.41	103	39	9.51	108
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-193	-1,016	-892	-802	-143
Total Preferred & Common Equity	-193	-1,016	-892	-802	-143
Preferred Stock	-	0.00	0.00	0.00	0.00
Total Common Equity	-193	-1,016	-892	-802	-143
Common Stock	6.15	12	24	39	361
Retained Earnings	-199	-1,028	-925	-847	-507
Accumulated Other Comprehensive Income / (Loss)	-	0.00	8.28	4.99	2.54

This table presents CompoSecure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	152	170	186	181	195	214	213	435	292
Total Current Assets	91	103	117	112	128	151	136	157	11
Cash & Equivalents	13	15	23	23	24	55	35	53	9.51
Accounts Receivable	45	46	39	37	49	35	40	44	1.32
Inventories, net	29	39	51	49	52	55	58	55	0.00
Plant, Property, & Equipment, net	21	23	24	24	23	25	24	23	0.00
Total Noncurrent Assets	40	44	44	45	44	38	53	256	281
Long-Term Investments	-	-	-	-	-	-	-	-	15
Noncurrent Deferred & Refundable Income Taxes	25	25	28	28	28	26	41	245	267
Other Noncurrent Operating Assets	15	19	16	17	16	13	12	10	0.00
Total Liabilities & Shareholders' Equity	152	170	186	181	195	214	213	435	292
Total Liabilities	487	495	477	453	434	411	422	720	380
Total Current Liabilities	40	67	59	51	53	42	49	65	47
Short-Term Debt	5.00	9.69	19	19	10	12	13	10	0.00
Accounts Payable	6.86	13	15	6.64	14	4.75	9.43	9.69	4.03
Accrued Expenses	23	20	12	11	14	13	12	13	29
Current Deferred & Payable Income Tax Liabilities	-	-	2.37	1.67	1.67	1.43	1.43	0.12	5.17
Other Current Liabilities	4.34	24	10	13	13	11	13	31	9.30
Total Noncurrent Liabilities	447	428	418	402	381	369	373	656	333
Long-Term Debt	377	358	339	335	331	320	314	316	0.00
Capital Lease Obligations	-	-	-	-	-	-	-	-	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	25	24	24	24	43	234	249
Other Noncurrent Operating Liabilities	70	70	53	43	27	24	16	105	84
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-942	-928	-888	-868	-835	-794	-726	-285	-87
Total Preferred & Common Equity	-942	-928	-888	-868	-835	-794	-726	-285	-87
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-942	-928	-888	-868	-835	-794	-726	-285	-87
Common Stock	18	21	26	30	35	41	36	180	206
Retained Earnings	-965	-958	-920	-907	-878	-840	-767	-468	-294
Accumulated Other Comprehensive Income / (Loss)	5.36	9.00	6.63	7.91	7.65	5.44	4.85	2.57	-0.21

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	7.11%	2.83%	41.25%	3.21%	7.67%
EBITDA Growth	0.00%	-1.74%	11.76%	59.45%	-10.56%	-136.76%
EBIT Growth	0.00%	-3.65%	11.69%	68.45%	-10.67%	-146.77%
NOPAT Growth	0.00%	-3.41%	-2.01%	35.18%	2.91%	-34.18%
Net Income Growth	0.00%	-4.49%	7.20%	58.03%	-14.64%	-173.91%
EPS Growth	0.00%	0.00%	0.00%	841.67%	-15.04%	-227.08%
Operating Cash Flow Growth	0.00%	7.24%	-10.66%	19.29%	12.43%	24.20%
Free Cash Flow Firm Growth	0.00%	0.00%	411.78%	-90.36%	323.34%	170.63%
Invested Capital Growth	0.00%	0.00%	-184.28%	224.46%	82.80%	-122.34%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	5.14%	1.59%	0.23%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	4.00%	8.35%	-271.87%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	4.68%	9.10%	-401.32%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	14.56%	2.16%	102.78%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	1.80%	8.35%	-2,100.05%
EPS Q/Q Growth	0.00%	0.00%	0.00%	7.62%	2.13%	-212.82%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	-16.93%	17.60%	7.45%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	16.56%	107.35%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	92.57%	22.36%	-88.97%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	52.56%	50.90%	54.06%	58.03%	53.52%	52.13%
EBITDA Margin	39.25%	36.01%	39.14%	44.18%	38.29%	-13.07%
Operating Margin	35.73%	32.22%	30.39%	30.36%	30.49%	25.59%
EBIT Margin	35.44%	31.88%	34.63%	41.30%	35.74%	-15.53%
Profit (Net Income) Margin	33.49%	29.86%	31.13%	34.83%	28.80%	-19.77%
Tax Burden Percent	100.00%	100.00%	101.04%	96.80%	96.11%	102.70%
Interest Burden Percent	94.49%	93.66%	88.97%	87.12%	83.85%	124.01%
Effective Tax Rate	0.00%	0.00%	-1.04%	3.20%	3.89%	0.00%
Return on Invested Capital (ROIC)	0.00%	336.43%	2,097.13%	2,161.43%	154.60%	202.71%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	331.36%	2,097.50%	2,167.23%	154.00%	127.87%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-417.25%	-2,124.92%	-2,199.11%	-199.81%	-155.09%
Return on Equity (ROE)	0.00%	-80.82%	-27.80%	-37.68%	-45.21%	47.63%
Cash Return on Invested Capital (CROIC)	0.00%	136.43%	0.00%	32.08%	96.04%	0.00%
Operating Return on Assets (OROA)	0.00%	102.12%	87.25%	106.22%	76.72%	-19.35%
Return on Assets (ROA)	0.00%	95.65%	78.43%	89.58%	61.83%	-24.64%
Return on Common Equity (ROCE)	0.00%	-80.82%	-55.97%	-102.77%	-153.91%	128.99%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-40.41%	-8.21%	-14.77%	-14.02%	57.97%
Net Operating Profit after Tax (NOPAT)	87	84	82	111	114	75
NOPAT Margin	35.73%	32.22%	30.70%	29.39%	29.30%	17.91%
Net Nonoperating Expense Percent (NNEP)	0.00%	5.07%	-0.38%	-5.80%	0.60%	74.84%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-20.82%	-24.90%	134.33%
Cost of Revenue to Revenue	47.44%	49.10%	45.94%	41.97%	46.48%	47.87%
SG&A Expenses to Revenue	16.83%	18.68%	23.67%	27.68%	23.04%	26.54%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	16.83%	18.68%	23.67%	27.68%	23.04%	26.54%
Earnings before Interest and Taxes (EBIT)	86	83	93	156	140	-65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	96	94	105	167	150	-55
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.90	1.07	0.85	0.75	0.83	2.55
Price to Earnings (P/E)	2.70	3.59	71.94	15.25	16.90	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	2.46%
Earnings Yield	37.03%	27.85%	1.39%	6.56%	5.92%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	10.46	0.00	23.48	12.78	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	2.00	4.48	3.25	3.13	2.84
Enterprise Value to EBITDA (EV/EBITDA)	0.00	5.56	11.45	7.35	8.18	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	6.28	12.94	7.86	8.76	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	6.22	14.60	11.05	10.69	15.88
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	5.99	15.44	13.25	11.73	9.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	15.33	6.89	73.19	17.20	6.22
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	-1.33	-0.95	-1.23	-1.67	-1.39
Long-Term Debt to Equity	0.00	-1.20	-0.92	-1.18	-1.62	-1.31
Financial Leverage	0.00	-1.26	-1.01	-1.01	-1.30	-1.21
Leverage Ratio	0.00	-0.42	-0.35	-0.42	-0.73	-1.93
Compound Leverage Factor	0.00	-0.40	-0.32	-0.37	-0.61	-2.40
Debt to Total Capital	0.00%	404.03%	-1,925.99%	542.43%	250.28%	355.78%
Short-Term Debt to Total Capital	0.00%	37.89%	-62.12%	21.78%	7.53%	20.06%
Long-Term Debt to Total Capital	0.00%	366.14%	-1,863.87%	520.66%	242.75%	335.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	-3,023.26%	909.47%	435.71%	0.00%
Common Equity to Total Capital	0.00%	-304.03%	5,049.26%	-1,351.91%	-585.99%	-255.78%
Debt to EBITDA	0.00	2.73	3.70	2.14	2.29	-3.63
Net Debt to EBITDA	0.00	2.58	3.49	2.06	2.02	-2.22
Long-Term Debt to EBITDA	0.00	2.47	3.58	2.05	2.22	-3.43
Debt to NOPAT	0.00	3.05	4.71	3.22	2.99	2.65
Net Debt to NOPAT	0.00	2.89	4.44	3.10	2.63	1.62
Long-Term Debt to NOPAT	0.00	2.76	4.56	3.09	2.90	2.50
Altman Z-Score	0.00	3.94	-6.17	-1.71	-0.60	0.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	-101.35%	-172.74%	-240.44%	-170.83%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.29	1.29	2.05	3.40	2.28
Quick Ratio	0.00	0.53	0.82	1.08	1.99	1.64
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	34	174	17	71	192
Operating Cash Flow to CapEx	842.00%	1,160.67%	1,638.85%	1,024.89%	953.14%	1,534.08%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.79	2.58	9.47
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	4.34	3.79	6.37
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	3.92	3.39	5.96
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	3.20	2.52	2.57	2.15	1.25
Accounts Receivable Turnover	0.00	29.64	14.60	11.61	10.05	9.57
Inventory Turnover	0.00	4.24	4.40	4.66	3.83	4.14
Fixed Asset Turnover	0.00	9.35	10.71	16.88	16.32	17.29
Accounts Payable Turnover	0.00	52.85	25.97	22.39	29.47	24.06
Days Sales Outstanding (DSO)	0.00	12.31	25.01	31.44	36.33	38.16
Days Inventory Outstanding (DIO)	0.00	86.14	83.03	78.34	95.41	88.26
Days Payable Outstanding (DPO)	0.00	6.91	14.05	16.30	12.38	15.17
Cash Conversion Cycle (CCC)	0.00	91.55	93.98	93.48	119.36	111.25
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	50	-42	52	96	-21
Invested Capital Turnover	0.00	10.44	68.30	73.55	5.28	11.32
Increase / (Decrease) in Invested Capital	0.00	50	-92	94	43	-117
Enterprise Value (EV)	0.00	522	1,201	1,229	1,223	1,196
Market Capitalization	220	279	227	285	325	1,074
Book Value per Share	$0.00	($6.65)	($35.10)	($11.69)	($10.12)	($1.63)
Tangible Book Value per Share	$0.00	($6.65)	($35.10)	($11.69)	($10.12)	($1.63)
Total Capital	0.00	63	-20	66	137	56
Total Debt	0.00	256	388	358	343	200
Total Long-Term Debt	0.00	232	375	344	332	188
Net Debt	0.00	242	366	344	301	122
Capital Expenditures (CapEx)	9.64	7.50	4.75	9.05	11	8.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	22	8.31	50	68	31
Debt-free Net Working Capital (DFNWC)	0.00	36	30	64	109	109
Net Working Capital (NWC)	0.00	12	18	50	98	98
Net Nonoperating Expense (NNE)	5.45	6.14	-1.14	-21	1.93	158
Net Nonoperating Obligations (NNO)	0.00	242	366	344	301	122
Total Depreciation and Amortization (D&A)	9.28	11	12	11	9.93	10
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	8.62%	3.10%	13.34%	17.28%	7.46%
Debt-free Net Working Capital to Revenue	0.00%	13.77%	11.29%	16.94%	27.83%	25.88%
Net Working Capital to Revenue	0.00%	4.56%	6.63%	13.15%	25.19%	23.20%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.91	$1.21	$1.03	($1.22)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	14.93M	15.37M	18.66M	44.01M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.14	$1.13	$0.96	($1.22)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	94.93M	32.56M	35.31M	44.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	76.07M	77.88M	80.53M	102.31M
Normalized Net Operating Profit after Tax (NOPAT)	61	59	57	111	114	75
Normalized NOPAT Margin	25.01%	22.55%	21.27%	29.39%	29.30%	17.91%
Pre Tax Income Margin	33.49%	29.86%	30.81%	35.98%	29.97%	-19.25%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	7.31	5.07	-3.21
NOPAT to Interest Expense	0.00	0.00	0.00	5.20	4.16	3.71
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	6.89	4.68	-3.63
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	4.78	3.76	3.29
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	127.41%	278.44%	288.48%	27.53%	34.09%	-71.38%
Augmented Payout Ratio	127.41%	278.44%	288.48%	27.53%	34.09%	-71.38%

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	56.09%	24.55%	13.22%	1.37%	-6.21%	6.52%	9.12%	10.19%	10.58%	0.96%	-42.48%
EBITDA Growth	24.42%	25.89%	-48.20%	-41.72%	57.04%	36.82%	34.55%	1.16%	-262.55%	-203.03%	52.00%
EBIT Growth	30.17%	32.14%	-51.54%	-42.62%	62.02%	40.51%	40.60%	0.13%	-278.01%	-215.25%	62.18%
NOPAT Growth	16.64%	151.59%	13.41%	-10.41%	11.55%	12.15%	-1.77%	7.04%	-27.53%	-59.73%	-96.35%
Net Income Growth	17.12%	11.67%	-60.10%	-46.07%	73.79%	38.78%	59.01%	2.71%	-324.64%	-255.87%	25.88%
EPS Growth	0.00%	66.67%	-52.17%	-44.23%	88.89%	10.00%	54.55%	10.34%	-423.53%	-377.27%	-58.82%
Operating Cash Flow Growth	46.69%	-63.60%	109.06%	-28.87%	-18.55%	144.25%	35.56%	14.83%	13.01%	33.99%	-91.08%
Free Cash Flow Firm Growth	0.00%	0.00%	-103.47%	-98.03%	-112.26%	76.89%	71.13%	100.43%	579.24%	888.57%	8,211.08%
Invested Capital Growth	-85.62%	224.46%	1,406.57%	77.10%	187.70%	82.80%	78.90%	40.73%	-114.46%	-122.34%	-240.24%
Revenue Q/Q Growth	6.28%	-9.21%	1.63%	3.37%	-1.67%	3.11%	4.11%	4.38%	-1.32%	-5.86%	-40.69%
EBITDA Q/Q Growth	-57.56%	3.85%	-42.49%	129.94%	14.35%	-9.52%	-43.44%	72.88%	-283.74%	42.65%	183.44%
EBIT Q/Q Growth	-59.54%	4.24%	-46.44%	153.99%	14.24%	-9.60%	-46.40%	80.88%	-303.11%	41.47%	175.42%
NOPAT Q/Q Growth	-23.43%	-4.01%	37.85%	-11.57%	-4.66%	-3.50%	20.73%	-3.63%	-35.46%	-46.37%	-89.07%
Net Income Q/Q Growth	-63.91%	2.11%	-51.97%	204.65%	16.32%	-18.46%	-44.97%	96.78%	-354.41%	43.42%	144.44%
EPS Q/Q Growth	-65.38%	11.11%	-45.00%	163.64%	17.24%	-35.29%	-22.73%	88.24%	-443.75%	44.55%	111.48%
Operating Cash Flow Q/Q Growth	-22.57%	-64.60%	130.06%	12.80%	-11.34%	6.17%	27.69%	-4.45%	-12.75%	25.88%	-91.50%
Free Cash Flow Firm Q/Q Growth	-0.70%	-137.56%	88.30%	145.23%	-716.79%	29.21%	85.38%	414.04%	1,374.81%	16.48%	50.36%
Invested Capital Q/Q Growth	-18.61%	92.57%	-15.00%	32.94%	32.21%	22.36%	-16.81%	4.58%	-113.59%	-88.97%	-422.25%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	59.78%	53.60%	55.98%	54.74%	50.47%	52.95%	53.08%	51.65%	51.72%	52.09%	48.06%
EBITDA Margin	29.18%	33.37%	18.89%	42.01%	48.86%	42.87%	23.29%	38.57%	-71.82%	-43.75%	61.54%
Operating Margin	24.82%	26.50%	30.86%	30.80%	29.73%	30.56%	29.94%	29.28%	27.15%	15.47%	10.10%
EBIT Margin	26.70%	30.66%	16.16%	39.71%	46.13%	40.45%	20.82%	36.08%	-74.26%	-46.17%	58.71%
Profit (Net Income) Margin	21.19%	23.84%	11.26%	33.20%	39.27%	31.06%	16.41%	30.95%	-79.78%	-47.95%	35.93%
Tax Burden Percent	98.24%	97.29%	113.33%	97.12%	97.57%	88.83%	105.15%	99.24%	100.74%	104.62%	63.87%
Interest Burden Percent	80.79%	79.90%	61.51%	86.09%	87.26%	86.43%	74.98%	86.43%	106.64%	99.26%	95.82%
Effective Tax Rate	1.76%	2.71%	-13.33%	2.88%	2.43%	11.17%	-5.15%	0.76%	0.00%	0.00%	80.24%
Return on Invested Capital (ROIC)	81.19%	1,896.28%	574.15%	252.68%	211.60%	143.23%	202.54%	167.06%	238.43%	122.53%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	79.32%	1,895.76%	567.84%	253.60%	214.58%	144.44%	197.42%	167.71%	202.59%	94.54%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-205.63%	-1,923.65%	-608.19%	-292.28%	-254.70%	-187.41%	-247.58%	-217.37%	-228.47%	-114.67%	0.00%
Return on Equity (ROE)	-124.44%	-27.37%	-34.04%	-39.60%	-43.10%	-44.17%	-45.05%	-50.31%	9.96%	7.87%	55.32%
Cash Return on Invested Capital (CROIC)	0.00%	32.08%	296.27%	180.61%	115.74%	96.04%	130.26%	131.93%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	47.32%	78.86%	38.24%	93.25%	97.24%	86.81%	41.64%	74.89%	-98.85%	-57.54%	87.36%
Return on Assets (ROA)	37.55%	61.31%	26.66%	77.97%	82.78%	66.66%	32.83%	64.24%	-106.19%	-59.75%	53.46%
Return on Common Equity (ROCE)	-893.37%	-74.65%	-95.46%	-118.11%	-134.81%	-150.38%	-155.06%	-166.74%	21.29%	21.31%	171.25%
Return on Equity Simple (ROE_SIMPLE)	-13.96%	0.00%	-13.03%	-10.10%	-12.43%	0.00%	-14.97%	-16.50%	1.33%	0.00%	90.19%
Net Operating Profit after Tax (NOPAT)	25	24	33	29	28	27	33	32	20	11	1.19
NOPAT Margin	24.38%	25.78%	34.97%	29.92%	29.00%	27.15%	31.48%	29.06%	19.01%	10.83%	2.00%
Net Nonoperating Expense Percent (NNEP)	1.87%	0.51%	6.32%	-0.92%	-2.97%	-1.21%	5.11%	-0.66%	35.83%	27.99%	-16.07%
Return On Investment Capital (ROIC_SIMPLE)	-	-4.53%	-	-	-	-5.90%	-7.09%	-	-	19.47%	-1.37%
Cost of Revenue to Revenue	40.22%	46.40%	44.02%	45.26%	49.53%	47.05%	46.92%	48.35%	48.28%	47.91%	51.94%
SG&A Expenses to Revenue	34.96%	27.11%	25.12%	23.94%	20.74%	22.39%	23.15%	22.36%	24.56%	36.62%	37.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	34.96%	27.11%	25.12%	23.94%	20.74%	22.39%	23.15%	22.36%	24.56%	36.62%	37.95%
Earnings before Interest and Taxes (EBIT)	28	29	15	39	45	40	22	39	-80	-47	35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	30	31	18	41	47	43	24	42	-77	-44	37
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.01	0.75	1.40	1.31	1.27	0.83	1.11	1.34	2.74	2.55	2.95
Price to Earnings (P/E)	0.00	15.25	31.11	34.56	24.93	16.90	21.11	20.84	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.41%	2.14%	2.46%	31.97%
Earnings Yield	0.00%	6.56%	3.21%	2.89%	4.01%	5.92%	4.74%	4.80%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	48.51	23.48	33.24	24.36	17.90	12.78	16.52	16.30	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.66	3.25	3.80	3.69	3.64	3.13	3.29	3.31	3.39	2.84	2.89
Enterprise Value to EBITDA (EV/EBITDA)	8.20	7.35	9.83	11.93	10.14	8.18	8.45	8.68	44.46	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	8.83	7.86	10.57	13.00	10.94	8.76	9.02	9.30	65.62	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	13.59	11.05	13.23	13.18	12.50	10.69	11.35	11.49	0.00	15.88	18.83
Enterprise Value to Operating Cash Flow (EV/OCF)	11.81	13.25	13.99	15.27	15.79	11.73	11.63	11.56	11.79	9.23	11.01
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	73.19	21.05	17.24	22.95	17.20	16.27	14.44	0.00	6.22	4.37
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.13	-1.23	-1.23	-1.30	-1.43	-1.67	-1.68	-1.57	-1.15	-1.39	0.00
Long-Term Debt to Equity	-1.10	-1.18	-1.17	-1.23	-1.38	-1.62	-1.62	-1.50	-1.11	-1.31	0.00
Financial Leverage	-2.59	-1.01	-1.07	-1.15	-1.19	-1.30	-1.25	-1.30	-1.13	-1.21	-0.89
Leverage Ratio	-2.99	-0.42	-0.49	-0.55	-0.65	-0.73	-0.82	-0.82	-1.20	-1.93	-1.78
Compound Leverage Factor	-2.42	-0.34	-0.30	-0.47	-0.56	-0.63	-0.61	-0.71	-1.28	-1.92	-1.70
Debt to Total Capital	862.19%	542.43%	534.11%	432.49%	334.07%	250.28%	246.46%	276.24%	789.09%	355.78%	0.00%
Short-Term Debt to Total Capital	22.73%	21.78%	27.96%	22.93%	10.13%	7.53%	8.81%	11.32%	24.18%	20.06%	0.00%
Long-Term Debt to Total Capital	839.47%	520.66%	506.15%	409.56%	323.95%	242.75%	237.65%	264.92%	764.92%	335.72%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1,414.52%	909.47%	889.50%	729.53%	584.68%	435.71%	442.70%	435.29%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-2,176.71%	-1,351.91%	-1,323.61%	-1,062.02%	-818.75%	-585.99%	-589.16%	-611.54%	-689.09%	-255.78%	100.00%
Debt to EBITDA	2.29	2.14	2.38	2.93	2.47	2.29	2.13	2.10	10.20	-3.63	0.00
Net Debt to EBITDA	2.19	2.06	2.23	2.74	2.30	2.02	1.78	1.87	8.56	-2.22	0.00
Long-Term Debt to EBITDA	2.23	2.05	2.26	2.77	2.39	2.22	2.06	2.01	9.89	-3.43	0.00
Debt to NOPAT	3.78	3.22	3.20	3.23	3.04	2.99	2.86	2.78	-0.12	2.65	0.00
Net Debt to NOPAT	3.63	3.10	3.00	3.03	2.83	2.63	2.39	2.48	-0.10	1.62	0.00
Long-Term Debt to NOPAT	3.69	3.09	3.04	3.06	2.95	2.90	2.76	2.66	-0.12	2.50	0.00
Altman Z-Score	-4.54	-4.30	-3.50	-3.05	-2.44	-2.22	-2.05	-1.24	0.07	0.36	1.89
Noncontrolling Interest Sharing Ratio	-617.92%	-172.74%	-180.44%	-198.25%	-212.79%	-240.44%	-244.24%	-231.40%	-113.88%	-170.83%	-209.57%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.54	2.05	1.98	2.21	2.43	3.40	3.56	2.79	2.43	2.28	0.23
Quick Ratio	0.91	1.08	1.04	1.16	1.37	1.99	2.13	1.53	1.49	1.64	0.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	187	-70	-8.22	3.72	-23	-16	-2.37	7.45	110	128	192
Operating Cash Flow to CapEx	822.44%	590.72%	679.13%	1,382.77%	2,561.52%	618.32%	2,092.44%	1,684.90%	1,418.15%	1,207.12%	778.04%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-0.36	0.00	742.56	0.00	114.02
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	5.16	0.00	190.11	0.00	1.78
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	4.92	0.00	176.70	0.00	1.55
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.77	2.57	2.37	2.35	2.11	2.15	2.00	2.08	1.33	1.25	1.49
Accounts Receivable Turnover	0.00	11.61	10.02	9.57	8.15	10.05	10.75	10.75	9.09	9.57	20.66
Inventory Turnover	0.00	4.66	4.21	4.42	3.91	3.83	3.54	3.69	3.74	4.14	0.00
Fixed Asset Turnover	0.00	16.88	17.12	17.26	16.76	16.32	16.34	17.08	18.19	17.29	0.00
Accounts Payable Turnover	20.05	22.39	16.29	25.44	13.34	29.47	18.61	24.44	16.84	24.06	41.87
Days Sales Outstanding (DSO)	0.00	31.44	36.43	38.16	44.77	36.33	33.96	33.96	40.16	38.16	17.66
Days Inventory Outstanding (DIO)	0.00	78.34	86.60	82.56	93.39	95.41	103.15	98.93	97.70	88.26	0.00
Days Payable Outstanding (DPO)	18.20	16.30	22.41	14.35	27.36	12.38	19.61	14.94	21.68	15.17	8.72
Cash Conversion Cycle (CCC)	-18.20	93.48	100.62	106.37	110.80	119.36	117.49	117.95	116.18	111.25	8.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	27	52	45	59	78	96	80	83	-11	-21	-112
Invested Capital Turnover	3.33	73.55	16.42	8.45	7.30	5.28	6.43	5.75	12.54	11.32	-23.49
Increase / (Decrease) in Invested Capital	-162	94	42	26	51	43	35	24	-90	-117	-191
Enterprise Value (EV)	1,319	1,229	1,480	1,441	1,400	1,223	1,316	1,357	1,422	1,196	1,088
Market Capitalization	364	285	547	513	487	325	442	548	1,148	1,074	1,112
Book Value per Share	($12.19)	($11.69)	($11.40)	($11.08)	($10.57)	($10.12)	($9.86)	($9.00)	($3.48)	($1.63)	($0.85)
Tangible Book Value per Share	($12.19)	($11.69)	($11.40)	($11.08)	($10.57)	($10.12)	($9.86)	($9.00)	($3.48)	($1.63)	($0.85)
Total Capital	43	66	67	82	102	137	135	119	41	56	-87
Total Debt	367	358	358	354	341	343	332	328	326	200	0.00
Total Long-Term Debt	358	344	339	335	331	332	320	314	316	188	0.00
Net Debt	352	344	336	331	317	301	277	292	274	122	-24
Capital Expenditures (CapEx)	3.72	1.83	3.67	2.03	0.97	4.28	1.61	1.91	1.98	2.93	0.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	30	50	54	57	62	68	65	66	50	31	-46
Debt-free Net Working Capital (DFNWC)	46	64	77	80	86	109	120	101	102	109	-36
Net Working Capital (NWC)	36	50	58	61	75	98	108	87	92	98	-36
Net Nonoperating Expense (NNE)	3.30	1.82	23	-3.24	-9.95	-3.91	16	-2.05	106	59	-20
Net Nonoperating Obligations (NNO)	352	344	336	331	317	301	277	292	274	122	-24
Total Depreciation and Amortization (D&A)	2.56	2.55	2.60	2.27	2.64	2.42	2.57	2.70	2.62	2.44	1.70
Debt-free, Cash-free Net Working Capital to Revenue	8.47%	13.34%	13.94%	14.69%	16.10%	17.28%	16.30%	16.01%	11.81%	7.46%	-12.16%
Debt-free Net Working Capital to Revenue	12.76%	16.94%	19.73%	20.47%	22.29%	27.83%	30.11%	24.66%	24.36%	25.88%	-9.64%
Net Working Capital to Revenue	10.07%	13.15%	14.92%	15.68%	19.60%	25.19%	27.13%	21.37%	21.98%	23.20%	-9.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.18	$0.24	$0.13	$0.31	$0.39	$0.20	$0.20	$0.44	($1.10)	($0.76)	$0.21
Adjusted Weighted Average Basic Shares Outstanding	15.43M	15.37M	17.63M	18.54M	19.07M	18.66M	20.57M	25.44M	38.21M	44.01M	102.04M
Adjusted Diluted Earnings per Share	$0.18	$0.20	$0.11	$0.29	$0.34	$0.22	$0.17	$0.32	($1.10)	($0.61)	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	19.66M	32.56M	94.74M	35.53M	35.76M	35.31M	96.24M	96.64M	38.21M	44.01M	113.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	76.35M	77.88M	78.39M	79.00M	79.32M	80.53M	80.59M	81.91M	88.13M	102.31M	102.32M
Normalized Net Operating Profit after Tax (NOPAT)	25	24	21	29	28	27	22	32	20	11	4.23
Normalized NOPAT Margin	24.38%	25.78%	21.60%	29.92%	29.00%	27.15%	20.95%	29.06%	19.01%	10.83%	7.07%
Pre Tax Income Margin	21.57%	24.50%	9.94%	34.18%	40.25%	34.96%	15.61%	31.18%	-79.19%	-45.83%	56.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	3.31	0.00	-537.57	0.00	20.81
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	5.01	0.00	137.60	0.00	0.71
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	3.07	0.00	-550.98	0.00	20.58
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	4.76	0.00	124.19	0.00	0.48
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	196.05%	27.53%	39.78%	45.12%	37.66%	34.09%	32.64%	37.12%	-1,570.32%	-71.38%	-62.49%
Augmented Payout Ratio	196.05%	27.53%	39.78%	45.12%	37.66%	34.09%	32.64%	37.12%	-1,570.32%	-71.38%	-62.49%

Financials Breakdown Chart

Key Financial Trends

CompoSecure, Inc. (NASDAQ: CMPO) Financial Summary – Last 4 Years

CompoSecure’s financials over the past several years show a dynamic picture of fluctuating revenues, profitability, and cash flow. Below are the key trends and notable highlights based on the most recent quarterly statements and historical data.

Q1 2025 showed a positive net income of $21.5 million, a significant improvement from losses in prior quarters.
Operating revenue has generally grown from around $95 million in Q1 2023 to nearly $60 million in recent quarters, reflecting steady demand for CompoSecure’s offerings.
Gross profit margins are healthy and stable at around 48% in the latest quarter, suggesting effective cost controls relative to revenue.
Cash from operating activities remains positive, with $3 million generated in Q1 2025, indicating the company continues to generate cash from core operations despite capital expenditures.
Total equity, though negative, has shown signs of improvement compared to previous quarters, reflecting reduced accumulated losses.
Cash and equivalents decreased sharply in the latest quarter to $9.5 million from over $50 million in Q3 2024, suggesting higher cash burn or investment activities.
Significant non-cash adjustments in cash flows vary widely quarter to quarter, pointing to ongoing asset revaluations or deferred items that should be monitored carefully by investors.
Net loss was recorded in several quarters over 2023 and 2024, with the largest quarterly loss exceeding $85 million, driven largely by large other expenses or impairments.
Total liabilities increased substantially over the years, reaching over $379 million in Q1 2025, which together with negative shareholders’ equity suggests a leveraged balance sheet.
Interest expense remains material in recent quarters, negatively impacting net income and cash flows, with interest paid ranging in millions quarterly.

Summary: CompoSecure is showing signs of recovery in profitability and operating cash flow in early 2025 after significant losses in 2023 and 2024. The company has managed its cost of revenue well to sustain gross margins but continues to face challenges from high liabilities and interest expenses. The sharp reduction in cash and large investing outflows in the recent quarter warrant close attention to liquidity and capital allocation going forward. Overall, improvements in earnings are positive, but the financial leverage and cash burn remain potential risks for investors to weigh.

10/24/25 08:11 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About CompoSecure's Financials

When does CompoSecure's fiscal year end?

According to the most recent income statement we have on file, CompoSecure's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CompoSecure's net income changed over the last 5 years?

CompoSecure's net income appears to be on a downward trend, with a most recent value of -$83.16 million in 2024, falling from $81.47 million in 2019. The previous period was $112.52 million in 2023. View CompoSecure's forecast to see where analysts expect CompoSecure to go next.

What is CompoSecure's operating income?

CompoSecure's total operating income in 2024 was $107.62 million, based on the following breakdown:

Total Gross Profit: $219.23 million
Total Operating Expenses: $111.61 million

How has CompoSecure's revenue changed over the last 5 years?

Over the last 5 years, CompoSecure's total revenue changed from $243.29 million in 2019 to $420.57 million in 2024, a change of 72.9%.

How much debt does CompoSecure have?

CompoSecure's total liabilities were at $617.36 million at the end of 2024, a 51.8% increase from 2023, and a 125.4% increase since 2020.

How much cash does CompoSecure have?

In the past 4 years, CompoSecure's cash and equivalents has ranged from $13.42 million in 2020 to $77.46 million in 2024, and is currently $77.46 million as of their latest financial filing in 2024.

How has CompoSecure's book value per share changed over the last 5 years?

Over the last 5 years, CompoSecure's book value per share changed from 0.00 in 2019 to -1.63 in 2024, a change of -162.8%.

Related Companies

This page (NASDAQ:CMPO) was last updated on 10/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CompoSecure (CMPO) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About CompoSecure's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CompoSecure (CMPO) Financials

Annual Income Statements for CompoSecure

Quarterly Income Statements for CompoSecure

Annual Cash Flow Statements for CompoSecure

Quarterly Cash Flow Statements for CompoSecure

Annual Balance Sheets for CompoSecure

Quarterly Balance Sheets for CompoSecure

Annual Metrics And Ratios for CompoSecure

Quarterly Metrics And Ratios for CompoSecure

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About CompoSecure's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools